Home / Virtual products: Ag / Agalsidase beta 5mg powder for solution for infusion vials
Agalsidase beta 5mg powder for solution for infusion vials
- ID
- 41758111000001109
- Date
- 9 May 2023
- Previous ID
- 413468006
- Therapeutic Moiety
- Agalsidase beta
- Name
- Agalsidase beta 5mg powder for solution for infusion vials
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Date of name applicability
- 13 Jan 2009
- Previous name
- Agalsidase beta 5mg powder for solution for injection vials
- Basis of previous name
- rINN - Recommended International Non-proprietary
- Reason for name change
- Other
- Prescribing status
- Valid as a prescribable product
- Dose form
- Discrete
- Unit dose form size
- 1.000
- Unit dose form units
- vial
- Unit dose unit of measure
- vial
- Ingredients
- Agalsidase beta
- Form & Route
- solutioninfusion.intravenous
- Drug formulations
- Powder for solution for infusion
- Drug route
- Intravenous
- Control drug
- No Controlled Drug Status